Clinical Trials

200 enrolled

Multiple Myeloma

NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

LymphoidOther hematologic neoplasmPlasma cell

68 enrolled

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT05646758 2024-03-18

A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects

140 enrolled

Multiple Myeloma

NCT06286241 2024-03-15

Step down ward

344 enrolled

Multiple Myeloma

NCT03975907 2024-03-12

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)

121 enrolled

Multiple Myeloma

NCT06302699 2024-03-12

Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma

80 enrolled

Multiple Myeloma, Neoplasm, Residual

NCT05697913 2024-03-06

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

66 enrolled

Multiple Myeloma, Neoplasm, Residual

NCT03428373 2024-02-29

RithMM

Phase 2/3 Unknown

57 enrolled

Multiple Myeloma

NCT05346198 2024-02-23

Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma

15 enrolled

Multiple Myeloma

NCT01754402 2024-02-20

Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

56 enrolled 12 charts

Multiple Myeloma

NCT06258096 2024-02-14

LI-TASTE

52 enrolled

Dysgeusia, Multiple Myeloma

NCT05840107 2024-02-13

Study of FasT CAR-T GC012F Injection NDMM Patients

18 enrolled

Multiple Myeloma

NCT06255639 2024-02-13

Biomechanical and Metabolic Assessment Pre and Post Vertebroplasty in Multiple Myeloma Patients With Vertebral Collapse

Multiple Myeloma

NCT06224309 2024-02-09

Preliminary Assessment of [18F]BL40 in PET/CT Scans

LymphoidOther hematologic neoplasmPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05478993 2024-01-31

SPODUMENE

21 enrolled

Multiple Myeloma

NCT06223646 2024-01-25

A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma

29 enrolled

Multiple Myeloma

NCT06205823 2024-01-16

CAREMM-2305

1,600 enrolled

Multiple Myeloma

NCT06203145 2024-01-12

A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM

Multiple Myeloma

NCT05308875 2024-01-05

Efficacy and Safety Evaluation of PD1-BCMA-CART

9 enrolled

Multiple Myeloma

NCT04714827 2023-12-29

Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma

24 enrolled

Multiple Myeloma

NCT04727008 2023-12-12

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

12 enrolled

Multiple Myeloma

NCT04877275 2023-12-06

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

50 enrolled

Multiple Myeloma

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT06154317 2023-12-04

Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)

Multiple Myeloma

NCT05280275 2023-12-01

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible

36 enrolled

Blood Protein Disorders, Corneal Diseases, Hematologic Diseases, Multiple Myeloma, Neoplasms, Paraproteinemias, Neoplasms, Plasma Cell

NCT06126237 2023-11-13

A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma

120 enrolled

Classical hematologyLymphoidPlasma cell

Multiple Myeloma

NCT06116734 2023-11-03

Lapelga vs Gastrofil

Phase 3 Unknown

74 enrolled

Lymphoma, Multiple Myeloma, Patient Participation, Febrile Neutropenia

NCT04519476 2023-10-31

Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.

22 enrolled

Multiple Myeloma

NCT04942067 2023-10-25

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma

108 enrolled

Amyloidosis, Multiple Myeloma

NCT06067581 2023-10-05

the Safety and Efficacy of SENL103 Autologous T Cell Injection

Multiple Myeloma

NCT05378971 2023-10-04

Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma

15 enrolled

Multiple Myeloma

NCT06060080 2023-09-29

Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma

7 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT04888741 2023-09-28

MoTD

LymphoidMyeloidOther hematologic neoplasmPlasma cell

400 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

LymphoidOther hematologic neoplasmPlasma cell

50 enrolled

Leukemia, Lymphoma, Multiple Myeloma

NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

Phase 2/3 Unknown

Multiple Myeloma

NCT03490084 2023-08-28

PAMM-HAD1

300 enrolled

Multiple Myeloma

NCT04309981 2023-08-28

Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.

73 enrolled

Multiple Myeloma

NCT05995808 2023-08-16

Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests

Multiple Myeloma

NCT04211259 2023-08-07

Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

70 enrolled

Multiple Myeloma

NCT05005299 2023-08-01

VICTORY

LymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05964270 2023-07-27

ITUMM

150 enrolled

Multiple Myeloma

NCT04143932 2023-07-18

THD-MM-Reg

1,000 enrolled

Multiple Myeloma

NCT04836871 2023-07-13

Double Filtration Plasmapheresis Combined With Chemotherapy

Multiple Myeloma

NCT03695744 2023-07-10

Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma

27 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT04814615 2023-06-27

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

60 enrolled

Multiple Myeloma

NCT05920876 2023-06-27

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

100 enrolled

Multiple Myeloma, Recurrence

NCT03809780 2023-06-22

LENDER

70 enrolled

Multiple Myeloma

NCT03090659 2023-06-12

LEGEND-2

100 enrolled

Multiple Myeloma

NCT05855122 2023-06-02

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

Phase 4 Unknown

48 enrolled